Periscope Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Periscope Capital’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.5K	Sell	60,000 -65,000	-52%	-$65.2K	0.01%	296
2026 Q1	$17.5K	Buy	125,000 +25,000	+25%	+$5.72K	﹤0.01%	388
2025 Q4	$29.5K	Hold	100,000	–	–	﹤0.01%	298
2025 Q3	$29K	Hold	100,000	–	–	﹤0.01%	241
2025 Q2	$29.1K	Hold	100,000	–	–	0.01%	191
2025 Q1	$25.5K	Buy	+100,000	New	+$17.6K	0.01%	150

Other funds holding TDACW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

TCM

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Periscope Capital's TDACW Position: Q2 2026 in Review

Periscope Capital reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 52% in Q2 2026, selling an estimated $65.2K and leaving 60,000 shares worth $85.5K. The position accounts for 0.01% of the portfolio, ranked #296.

Periscope Capital first reported a position in TDACW in Q1 2025 and has held it in 6 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

Periscope Capital held 60,000 shares of Translational Development Acquisition Corp Warrants worth $85.5K as of Q2 2026.
Periscope Capital sold 65,000 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $65.2K.
Translational Development Acquisition Corp Warrants made up 0.01% of Periscope Capital's portfolio in Q2 2026, its #296 holding.
Periscope Capital first reported a position in Translational Development Acquisition Corp Warrants in Q1 2025 and has held it in 6 quarters since.
28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Periscope Capital's 13F filing for Q2 2026, filed 11 Aug 2026.